Talis Biomedical
Stock Forecast, Prediction & Price Target
Talis Biomedical Financial Estimates
Talis Biomedical Revenue Estimates
Talis Biomedical EBITDA Estimates
Talis Biomedical Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $3.65M 0% | $412K -88.71% | Avg: $13.00M Low: $13.00M High: $13.00M avg. 3056.43% | |||
Net Income
% change YoY
| $-190.45M N/A | $-110.88M 41.77% | $-62.00M 44.07% | Avg: $-50.48M Low: $-50.48M High: $-50.48M avg. 18.58% | |||
EBITDA
% change YoY
| $-191.81M N/A | $-115.13M 39.97% | $-66.04M 42.63% | Avg: $-7.80M Low: $-7.80M High: $-7.80M avg. 88.18% | |||
EPS
% change YoY
| -$126.13 N/A | -$62.45 50.48% | -$34.12 45.36% | Avg: -$27.78 Low: -$27.78 High: -$27.78 avg. 18.59% | |||
Operating Expenses
% change YoY
| $191.81M N/A | $110.4M -42.44% | $67.18M -39.14% | Avg: $167.83M Low: $167.83M High: $167.83M avg. 149.79% | |||
FAQ
What is Talis Biomedical stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 18.58% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -50.48M, average is -50.48M and high is -50.48M.
What is Talis Biomedical stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 3056.43% in 2025-2025.
We have gathered data from N/A analysts. Their low revenue estimate is $13.00M, average is $13.00M and high is $13.00M.
What is Talis Biomedical stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 18.59% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$27.78, average is -$27.78 and high is $-27.77.